home » conference proceedings

DEVELOPMENTS IN BIOLOGICALS

Other IABS publications.

Since 1965, lABS has convened more than 100 international meetings of contemporary interest in human and veterinary medicine followed by publication of the proceedings in the symposia series, Developments in Biologicals (previously called Developments in Biological Standardization). This page lists volumes from 1973 forward, along with the contents pages of the more recent volumes.

Volumes 23-92 are available to members of the lABS and the PDA at the special price of CHF 40. each.

Volumes from 93 onward have a special price for lABS and PDA members shown in bold. The normal retail prices are shown in parentheses. All prices are in Swiss francs.

lABS and PDA members should use the ORDER FORM (pdf) for ordering.
All other persons should order volumes directly from S. Karger A.G., P.O. Box, CH-4009 Basel, Switzerland.

in preparation

Vol. 129 The OlE Global Conference on Aquatic Animal Health, Bergen, 2006

Vol. 130 Vaccination: A Tool for the Control of Avian Influenza, Verona, 2007

DEVELOPMENTS IN BIOLOGICALS

Vol. 128 First International Conference of the OlE Reference Laboratories and Collaborating Centers , Florianopolis, 2006 (216 p.), CHF 130..- (CHF 195.-). ISBN 978-3-8055-8321-3

Vol. 127 Advances in Transfusion Safety - Volume IV, Sydney, 2005 (288 p.), CHF 175.- (CHF 260.-). ISBN-10: 3-8055-8239-0, ISBN-13: 978-3-8055-8239-1

Vol. 126 New Diagnostic Technology: Applications in Animal Health & Biologics Control, Saint-Malo, 2005 (352 p.), CHF 215.- (CHF 320.-). ISBN-10: 3-8055-8116-5, ISBN-13: 978-3-80558116-5

Vol. 125 First International Conference on Rabies in Europe, Kiev, 2005 (344 p.), CHF 210.- (CHF 310.-). ISBN-10: 3-8055-8115-7, ISBN-13: 978-3-8d55-8115-8

Vol. 124 OIE/FAO International Scientific Conference on Avian Influenza Paris, 2005 (288 p.), CHF 175.- (CHF 260.-). ISBN 3-8055-8031-2

Vol. 123 Vaccine Cell Substrates 2004, Rockville, 2004 (376 p.), CHF 230.- (CHF 340.-).

Vol. 122 State of the Art Analytical Methods for Characterization Of Biological Products and Assessment of Comparability, Bethesda, 2003 (224 p.), CHF 135.- (CHF 200.-). ISBN 3-8055-7998-5

Vol. 121 Progress in Fish Vaccinology, Bergen, 2003 (352 p.), CHF 210.- (CHF 315.-). ISBN 3-8055-7936-5
[Further Information]*

Vol. 120 Advances in Transfusion Safety, Bethesda, MD, 2003 (240 p.), CHF 150.- (CHF 216.-). ISBN 3-8055-7935-7
[Further Information]*

Vol. 119 Control of Infectious Animal Diseases by Vaccination, Buenos Aires, (528 p.), CHF 320.- (CHF 475.-). ISBN 3-8055-7874-1
[Further Information]*

Vol. 118 PDA/EMEA European Virus Safety Forum, Langen, 2003 (192 pp.), Sfr. 120.- (Sfr. 175.-). ISBN 3-8055-7873-3
[Further Information]*

Vol. 117 Consideration of Alternative Licensing Procedures for Vaccines for Minor Species, Minor Indications and Autogenous/Autologous Products, Langen, 2003 (192 pp.), Sfr. 120.- (Sfr. 175.-). ISBN 3-8055-7737-0
[Further Information]*

Vol. 116 Development of Therapeutic Cancer Vaccines, Los Angeles, 2003 (260 pp.), Sfr. 160.- (Sfr. 235.-). ISBN 3-8055-7736-2
[Further Information]*

Vol. 115 Laboratory Correlates of Immunity to Influenza - A Reassessment, Bergen, 2002 (176 pp.), Sfr. 110.- (Sfr. 160). ISBN 3-8055-7735-4
[Further Information]*

Vol. 114 Vaccines for OIE List A and Emerging Animal Diseases, Ames, 2002 (312 pp.) Sfr. 190.- (Sfr 280.-). ISBN 3-8055-7577-7
[Further Information]*

Vol. 113 Process Validation for Manufacturing of Biologics and Biotechnology, Berlin, 2001 (144 pp.), Sfr. 90.- (Sfr 130.-). ISBN 3-8055-7576-9
[Further Information]*

Vol. 112 Immunogenicity of Therapeutic Biological Products, Bethesda, 2001 (188 pp.), Sfr. 115.- (Sfr 170.-). ISBN 3-8055-7575-0
[Further Information]*

Vol. 111 Advancing Science and Elimination of the Use of Laboratory Animals for the Development and Control of Vaccines and Hormones, Utrecht, 2001 (356 pp.) Sfr. 215.- (Sfr 320.-). ISBN 3-8055-7509-2.
[Further Information]*

Vol. 110  Orphan Vaccines - Bridging the Gap, Palm Grove, 2001 (192 pp.), Sfr. 120.- (Sfr 180.-). ISBN 3-8055-7508-4.
[Further Information]*

Vol. 109 Biologics 2000 - Comparability of Biotechnology Products, Bethesda, 2000 (168 pp.) Sfr. 100.- (Sfr. 150.-). ISBN 3-8055-7427-4.
[Further Information]*

Vol. 108 Advances in Transfusion Safety - 2001, Langen, 2001 (160 pp.) Sfr. 100.- (Sfr. 145.-)
[Further Information]*

Vol. 107 The Design and Analysis of Potency Assays for Biotechnology Products, London, 2000 (152 pp.) Sfr. 95.- (Sfr. 140.-)
[Further Information]*

Vol. 106 Evolving Scientific and Regulatory Perspectives on Cell Substrates for Vaccine Development, Rockville, 1999, (560 pp.) Sfr. 335.- (Sfr. 500.-)
[Further Information]*

Vol. 105 Progress in Polio Eradication: Vaccine Strategies for the End Game, Paris, 2000, (260pp.) Sfr. 170.- (Sfr. 250.-)
[Further Information]*

Vol. 104 Developments and Clinical Progress of DNA Vaccines, Langen, 2000, (224pp.) Sfr. 130.- (Sfr. 200.-)
Further Information]*

Vol. 103 Physico-Chemical Procedures for the Characterization of Vaccines, Annecy, 1999, (292pp.) Sfr 180.- (Sfr. 270.-)
[Further Information]*

Vol. 102 Advances in Transfusion Safety, San Francisco, 1999, (264pp.) Sfr. 160.- (Sfr. 240.-)
[Further Information]*

DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION

Vol. 101 Alternatives to Animals in the Development and Control of Biological Products for Human and Veterinary Use, London, 1998, (352pp.) Sfr. 210.- (Sfr. 315.-) [Further Information]*

Vol. 100 A Celebration of 50 Years of Progress in Biological Standardization and Control at WHO, Geneva, 1998, (192pp.) Sfr. 115.- (Sfr. 170.-) [Further Information]*

Vol. 99 Animal Sera, Animal Sera Derivatives and Substitutes Used in the Manufacture of Pharmaceuticals: Viral Safety and Regulatory Aspects, Strasbourg, 1998, (216 pp.) Sfr. 130.- (Sfr. 200.-) [Further Information]*

Vol. 98 Inactivated Influenza Vaccines Prepared in Cell Culture, London, 1997, (224 pp.) Sfr. 135.- (Sfr. 200.-) [Further Information]*

Vol. 97 Biological Characterization and Assay of Cytokines and Growth Factors, London, 1997, (204 pp.) Sfr. 125.- (Sfr. 185.-) [Further Information]*

Vol. 96 Characterization of Biotechnology Pharmaceutical Products, Washington, DC, 1995, (224 pp.) Sfr. 135.- (Sfr. 200.-) [Further Information]*

Vol. 95 Preclinical and Clinical Development of New Vaccines, Paris, 1997, (296 pp.) Sfr. 180.- (Sfr. 270.-) [Further Information]*

Vol. 94 Simian Virus 40 (SV40): A Possible Human Polyomavirus, Bethesda, MD, 1997, (424 pp.) Sfr. 250.- (Sfr. 380.-) [Further Information]*

Vol. 93 Safety of Biological Products Prepared from Mammalian Cell Culture, Annecy, 1996, (256 pp.) Sfr. 140.- (Sfr. 230.-) [Further Information]*

Vol. 92 Modulation of the Immune Response to Vaccine Antigens, Bergen, 1996 (380 pp.) [Further Information]*

Vol. 91 Development of Specifications for Biotechnology Pharmaceuticals Products, San Francisco, CA, 1996 (132 pp.) [Further Information]*

Vol. 90 Fish Vaccinology, Oslo, 1996 (504 pp.) [Further Information]*

Vol. 89 Pertussis Vaccine Trials, Rome, 1995 (432 pp.) [Further Information]*

Vol. 88 Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products, Bethesda, MD, 1995 (360 pp.) [Further Information]*

Vol. 87 New Approaches to Stabilisation of Vaccines Potency, WHO Geneva, 1995 (376 pp.) 215.- (320.-)

Vol. 86 Replacement, Reduction and Refinement of Animal Experiments in the Development and Control of Biological Products, Langen, 1994

Vol. 85 Genetics of Streptococci, Enterococci and Lactococci, Santa Fé, NM, 1994 (680 pp.)

Vol. 84 Non-Target Effects of Live Vaccines, Langen, 1993 (308 pp.)

Vol. 83 Genetic Stability and Recombinant Product Consistency, Annecy, 1993 (216 pp.)

Vol. 82 Recombinant Vectors in Vaccine Development, Albany NY, 1993 (280 pp.)

Vol. 81 Virological Safety Aspects of Plasma Derivatives, Cannes, 1992 (300 pp.)

Vol. 80 Transmissible Spongiform Encephalopathies - Impact on Animal and Human Health, Heidelberg, 1992 (248 pp.)

Special supplementary issue in the Biologicals series published by Academic Press, London: Homage to Albert Sabin, Sfr. 25.-

Vol. 79 The First Steps Towards an International Harmonization of Veterinary Biologicals: 1993 and Free Circulation of Vaccines within the EEC, Ploufragan, 1992 (248 pp.)

Vol. 78 Poliovirus Attenuation: Molecular Mechanisms and Practical Aspects, Bethesda, MD, 1991 (200 pp.)

Vol. 77 Standardization of the Immunopharmacology of Natural and Synthetic Immunomodulators, Annecy, 1991 (264 pp.)

Vol. 76 Continuous Cell Lines - An International Workshop on Current Issues, Bethesda, MD, 1991 (368 pp.)

Vol. 75 Virological Aspects of the Safety of Biological Products, London, 1990 (290 pp.)

Vol. 74 Biological Product Freeze-drying and Formulation, Bethesda, MD, 1990 (400 pp.)

Vol. 73 Pertussis: Evaluation and Research on Acellular Pertussis Vaccines, Shizuoka, 1990 (396 pp.)

Vol. 72 Progress in Animal Retroviruses, Annecy, 1989 (400 pp.)

Vol. 71 Monoclonal Antibodies for Therapy, Prevention and in Vivo Diagnosis of Human Disease, Utrecht, 1989 (248 pp.)

Vol. 70 Continuous Cell Lines as Substrates for Biologicals, Arlington, 1988 (304 pp.)

Vol. 69 Cytokines Laboratory and Clinical Evaluation, London, 1987 (240 pp.)

Vol. 68 Cells - Products - Safety, WHO Geneva, 1986 (96 pp.)

Vol. 67 Standardization in Blood Fractionation Including Coagulation Factors, Melbourne, 1986 (382 pp.)

Vol. 66 Advances in Animal Cell Technology: Cell Engineering, Evaluation and Exploitation, Vienna, 1985 (604 pp.)

Vol. 65 Use and Standardization of Combined Vaccines, Amsterdam, 1985 (300 pp.)

Vol. 64 Reduction of Animal Usage in the Development and Control of Biological Products, London, 1985 (330 pp.)

Vol. 63 Use and Standardization of Chemically Defined Antigens, San Francisco, 1985 (161 pp.)

Vol. 62 Diagnostics and Vaccines for Parasitic Diseases, Stockholm, 1985 (158 pp.)

Vol. 61 Proceedings of the Fourth International Symposium on Pertussis, Geneva, 1984 (594 pp.)

Vol. 60 Production and Exploitation of Existing and New Animal Cell Substrates, Gardone Riviera, 1984 (540 pp.) - Out of print

Vol. 59 Standardization and Control of Biologicals Produced by Recombinant DNA Technology, Geneva, 1983 (209 pp.)

Vol. 58 International Symposium on BCG Vaccines and Tuberculins, Budapest, 1983 (782 pp.) - Out of print

Vol. 57 Monoclonal Antibodies: Standardization of their Characterization and use, Paris, 1983 (434 pp.)

Vol. 56 Third International Symposium on Brucellosis, Algiers, 1983 (779 pp.)

Vol. 55 Fifth General Meeting of ESCAT, Copenhagen, 1982 (289 pp.)

Vol. 54 Viral Hepatitis: Standardization in Immunoprophylaxis of Infections by Hepatitis Viruses, Athens, 1982 (585 pp.)

Vol. 53 Enteric Infections in Man and Animals: Standardization of Immunological Procedures, Dublin, 1982 (368 pp.)

Vol. 52 Herpes Virus of Man and Animal: Standardization of Immunological Procedures, Lyons, 1981 (571 pp.)

Vol. 51 Immunization of Adult Birds with Inactivated Oil Adjuvant Vaccines, Lyons, 1981 (336 pp.)

Vol. 50 The Use of Heteroploid and Other Cell Substrates for the Production of Biologicals, Heidelberg, 1981 (401 pp.)

Vol. 49 Fish Biologics: Serodiagnostics and Vaccines, Leetown, 1981 (489 pp.)

Vol. 48 Standardization of Albumin, Plasma Substitutes and Plasmapheresis, Geneva, 1980 (336 pp.)

Vol. 47 Reassessment of Inactivated Poliomyelitis Vaccine, Bilthoven, 1980 (364 pp.)

Vol. 46 Third General Meeting of ESACT, Oxford, 1979 (316 pp.)

Vol. 45 The Standardization of Animals to Improve Biomedical Research, Production and Control, San Antonio, 1979, (247 pp.)

Vol. 44 Test Methods for the Quality Control of Plasma Proteins, Villars, 1979, (222 pp.)

Vol. 43 Immunization: Benefit Versus Risk Factors, Brussels, 1978 (476 pp.)

Vol. 42 Second General Meeting of ESACT, Paris, 1978 (210 pp.)

Vol. 41 Vaccines in the Developing Countries, Guadeloupe, 1978 (446 pp.)

Vol. 40 Standardization of Rabies Vaccines for Human Use Produced in Tissue Culture (Rabies III), Marburg, 1977 (292 pp.)

Vol. 39 Influenza Immunization, Geneva, 1977 (564 pp.)

Vol. 38 Biological Preparations in the Treatment of Cancer, London, 1977 (632 pp.)

Vol. 37 Standardization of Cell Substrates for the Production of Virus Vaccines, Geneva, 1976 (336 pp.)

Vol. 36 Freeze-drying of Biological Products, Washington DC, 1976 (498 pp.)

Vol. 35 Foot-and-Mouth Disease (II), Lyons, 1976 (520 pp.) - Out of print

Vol. 34 Pyrogenicity, Innocuity and Toxicity Test Systems for Biological Products, Budapest, 1976 (238 pp.)

Vol. 33 Vaccination of Man and Animals by the Non-Parenteral Route, Douglas, Isle of Man, 1975 (454 pp.)

Vol. 32 Clostridial Products in Veterinary Medicine, Paris, 1975 (304 pp.)

Vol. 31 Second International Symposium on Brucellosis, Rabat, 1975 (428 pp.)

Vol. 30 Viral Hepatitis, Milan, 1974 (500 pp.)

Vol. 29 Standardization and Control of Allergens Administered to Man, Geneva, 1974 (450 pp.)

Vol. 28 Immunity to Infections of the Respiratory System in Man and Animals, London, 1974 (650 pp.) - Out of print

Vol. 27 Purity of Human Plasma Proteins, Budapest, 1973 (270 pp.)

Vol. 26 Selected Veterinary Vaccines, Budapest, 1973 (60 pp.)

Vol. 25 Requirements for Poultry Virus Vaccines, Lyons, 1973 (430 pp.)

Vol. 24 Preservatives in Biological Products, San Francisco, 1973 (270 pp.) - Out of print

Vol. 23 Sterilization and Sterility Testing of Biological Substances, Madrid, 1973 (200 pp.) - Out of print

updated 10 October 2007

Back to top